Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

Monday’s trading has closed, but HRTX is being traded in the after-hours session. After-Hours quote »
17.35
Delayed Data
As of 3:59pm ET
 -1.94 / -10.06%
Today’s Change
8.10
Today|||52-Week Range
42.25
-35.02%
Year-to-Date

Today’s Trading

Previous close19.29
Today’s open18.65
Day’s range16.23 - 19.32
Volume1,320,172
Average volume (3 months)848,124
Market cap$693.9M
Dividend yield--
Data as of 3:59pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+5.01%
Earnings growth (next 5 years)+56.17%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.94

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-0.11-0.52%
MACKMerrimack Pharmaceut...-0.62-10.26%
CLLSCellectis SA-0.96-4.70%
NLNKNewLink Genetics Cor...-2.37-10.20%
Data as of 3:59pm ET, 02/08/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers